Ensuring animal welfare while meeting scientific aims using a murine pneumonia model of septic shock

Shock

Volumn 39, Issue 6, 2013, Pages 488-494

  Huet, Olivier ^a   Ramsey, Debbie ^a   Miljavec, Sandra ^a   Jenney, Adam ^b,c   Aubron, Cecile ^d   Aprico, Andrea ^a   Stefanovic, Nada ^a   Balkau, Beverley ^e,f   Head, Geoff A ^a   De Haan, Judy B ^a   Chin Dusting, Jaye P F ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b Lab of Infectious Diseases   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Animal welfare; mouse; pneumonia; septic shock

Indexed keywords

CREATININE; CYTOKINE; LIVER ENZYME; UREA; BIOLOGICAL MARKER;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL WELFARE; ARTICLE; BACTEREMIA; CLINICAL ASSESSMENT TOOL; CORRELATION COEFFICIENT; DISEASE ASSESSMENT; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; INTERNAL CONSISTENCY; MALE; MEDICAL RESEARCH; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; SCORING SYSTEM; SEPTIC SHOCK; ANIMAL; BACTERIAL COUNT; BACTERIAL PNEUMONIA; BLOOD; C57BL MOUSE; COMPLICATION; DISEASE COURSE; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; KLEBSIELLA INFECTION; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; STANDARDS;

ANIMAL WELFARE; ANIMALS; BIOLOGICAL MARKERS; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; PNEUMONIA, BACTERIAL; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

EID: 84891596763     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182939831     Document Type: Article

References (31)

1. Stokes WS: Best practices for the use of animals in toxicological research and testing. Ann N Y Acad Sci 1245:17-20, 2011.
2. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA, Glennie MJ, et al.: Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102:1555-1577, 2010.
3. Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG: Humane endpoints in shock research. Shock (Augusta, Ga) 21:17-25, 2004.
4. Nemzek JA, Hugunin KM, Opp MR: Modeling sepsis in the laboratory: Merging sound science with animal well-being. Comp Med 58:120-128, 2008.
5. Calvano SE: Re: Humane endpoints in shock research. Shock 22:189, 2004; author reply 189-190.
6. Brealey D, Karyampudi S, Jacques TS, Novelli M, Stidwill R, Taylor V, Smolenski RT, Singer M: Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 286: R491-R497, 2004.
7. Albuszies G, Vogt J, Wachter U, Thiemermann C, Leverve XM, Weber S, Georgieff M, Radermacher P, Barth E: The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock. Intensive Care Med 33:1094-1101, 2007.
8. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
9. Esmon CT: Why do animal models (sometimes) fail to mimic human sepsis?. Crit Care Med 32:S219-S222, 2004.
10. Gurkan OU, He C, Zielinski R, Rabb H, King LS, Dodd-o JM, D'Alessio FR, Aggarwal N, Pearse D, Becker PM: Interleukin-6 mediates pulmonary vascular permeability in a two-hit model of ventilator-associated lung injury. Exp Lung Res 37:575-584, 2011.
11. Davis CG, Chang K, Osborne D, Walton AH, Dunne WM, Muenzer JT: Increased susceptibility to Candida infection following cecal ligation and puncture. Biochem Biophys Res Commun 414:37-43, 2011.
12. Marshall JC, Deitch E, Moldawer LL, Opal S, Redl H, van der Poll T: Preclinical models of shock and sepsis: what can they tell us?. Shock 24(Suppl 1): 1-6, 2005.
13. Miles AA, Misra SS, Irwin JO: The estimation of the bactericidal power of the blood. J Hyg 38:732-749, 1938.
14. Langford DJ, Bailey AL, Chanda ML, Clarke SE, Drummond TE, Echols S, Glick S, Ingrao J, Klassen-Ross T, Lacroix-Fralish ML, et al.: Coding of facial expressions of pain in the laboratory mouse. Nat Methods 7:447-449, 2010.
15. Moore TA, Moore BB, Newstead MW, Standiford TJ: Gamma delta-T cells are critical for survival and early proinflammatory cytokine gene expression during murine Klebsiella pneumoniae. J Immunol 165:2643-2650, 2000.
16. Moore TA, Newstead MW, Strieter RM, Mehrad B, Beaman BL, Standiford TJ: Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection. J Immunol 164:908-915, 2000.
17. Standiford TJ, Tsai WC, Mehrad B, Moore TA: Cytokines as targets of immunotherapy in bacterial pneumonia. J Lab Clin Med 135:129-138, 2000.
18. Krarup A, Chattopadhyay P, Bhattacharjee AK, Burge JR, Ruble GR: Evaluation of surrogate markers of impending death in the galactosamine-sensitized murine model of bacterial endotoxemia. Lab Anim Sci 49:545-550, 1999.
19. IACUC policy of establishing humane endpoints. Available at: Http://www. research.uci.edu/ora/acup/humaneEndpoints.htm. Accessed April 17, 2013.
20. Recognizing pain in animals. Available at: Http://dels.nas.edu/animal-pain/ index.shtml. Accessed April 17, 2013.
21. OECD: Guidance Documentation of the Recognition, Assessment, and Use of Clinical Signs as Humane End-Points for Experimental Animals Used in Safety Evaluation. OECD Environment Directorate, ed. Paris, France: OECD Head of Publication Service; 2000:39.
22. Morton DB, Griffiths PH: Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Rec 116:431-436, 1985.
23. Osuchowski MF, Welch K, Siddiqui J, Remick DG: Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol (Baltimore, Md, 1950) 177:1967-1974, 2006.
24. Chew P, Yuen DY, Stefanovic N, Pete J, Coughlan MT, Jandeleit-Dahm KA, Thomas MC, Rosenfeldt F, Cooper ME, de Haan JB: Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. Diabetes 59:3198-3207, 2009.
25. Cornelli U, Terranova R, Luca S, Cornelli M, Alberti A: Bioavailability and antioxidant activity of some food supplements in men and women using the D-ROMs test as a marker of oxidative stress. J Nutr 131:3208-3211, 2001.
26. CCAC/CCPA: Guidelines on Choosing an Appropriate Endpoint in Experiments Using Animals for Research, Teaching and Testing. CCAC/CCPA, ed. Ottowa, Canada: Canadian Council on Animal Care; 2000.
27. Olfert ED, Cross BM, Mc William A: Guide to the Care and Use of Experimental Animals. Vol. 1. Ottowa, Canada: Canadian Council on Animal Care; 1993.
28. Bozza FA, Salluh JI, Japiassu AM, Soares M, Assis EF, Gomes RN, Bozza MT, Castro-Faria-Neto HC, Bozza PT: Cytokine profiles as markers of disease severity in sepsis: A multiplex analysis. Crit Care 11:R49, 2007.
29. Mera S, Tatulescu D, Cismaru C, Bondor C, Slavcovici A, Zanc V, Carstina D, Oltean M: Multiplex cytokine profiling in patients with sepsis. APMIS 119:155-163, 2011.
30. Huet O, Obata R, Aubron C, Spraul-Davit A, Charpentier J, Laplace C, Nguyen-Khoa T, Conti M, Vicaut E, Mira JP, et al.: Plasma-induced endothelial oxidative stress is related to the severity of septic shock. Crit Care Med 35: 821-826, 2007.
31. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001.